Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Additional information Peer review information Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work
doi: 10.1126/sciadv.adh0980 85 TerrillSJJacksonCMGreeneHELillyNMaskeCBVallejoSet al
Legal disclaimer
Weight Loss Efficacy and Comparative Effectiveness Superior Performance of Dual-Agonist Therapies The SURMOUNT-5 head-to-head trial represents a landmark study comparing the two leading GLP-1 medications directly ^2
CROCC, also known as TAX1BP2, is a tumor-suppressor gene that was shown to suppress hepatocellular carcinoma via p38/p53/p21 pathway activation 38
US$ 23.97
US$ 20.42
US$ 23.59
US$ 23.92
US$ 21.85
